| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |